Live Breaking News & Updates on Biopharma Culture

Stay updated with breaking news from Biopharma culture. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Selkirk Pharma: Adapting to regulatory shifts and market demand

Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more. ....

Supply Chain , Digital Transformation Plan , Markets Amp Regulations , Bio Developments , Biopharma Culture , Emerging Markets , Contract Manufacturing , Supply Chain ,

Eli Lilly under pressure: Can it solve GLP-1 supply squeeze?

Specific doses of Eli Lilly’s GLP-1 blockbuster drugs Mounjaro and Zepbound are currently facing a supply shortage, and frustrated patients are urging the pharma giant to act – fast. ....

Republic Of , David Ricks , Eli Lilly , Vikram Shanbhag , Nicolas Schmitz , Lilly Mounjaro , Lars Fruergaard , Novo Nordisk Wegovy , Novo Nordisk , Dave Knapp , Novo Holdings , Bio Pharma , Big Night , Mounjaro User Dave Knapp , Markets Amp Regulations , Biopharma Culture , Emerging Markets , Eli Lilly , Novo Nordisk ,

Eli Lilly under pressure: Can they solve GLP-1 supply squeeze?

Specific doses of Eli Lilly’s GLP-1 blockbuster drugs Mounjaro and Zepbound are currently facing a supply shortage, and frustrated patients are urging the pharma giant to act – fast. ....

Republic Of , Eli Lilly , Novo Nordisk Wegovy , Nicolas Schmitz , Novo Nordisk , Dave Knapp , Lars Fruergaard , Lilly Mounjaro , Vikram Shanbhag , David Ricks , Novo Holdings , Bio Pharma , Big Night , Mounjaro User Dave Knapp , Markets Amp Regulations , Biopharma Culture , Emerging Markets , Eli Lilly , Novo Nordisk ,